Immuno-oncology Market Grow At Remarkable CAGR 16.5% CAGR with USD 37,783.6 Million by 2028 | Amgen, AstraZeneca Plc, Bristol-Myers Squibb Company, Merck & Co.

Global Immuno-Oncology Market

Immunotherapy includes treatments that work in different ways. Some boost the body’s immune system in a very general way and others help train the immune system to attack cancer cells specifically.

• Immune Checkpoint Inhibitors

One immunotherapy approach is to block the ability of certain proteins, called immune checkpoint proteins, to limit the strength and duration of immune responses

Some of the therapies currently marketed for this category include drugs that target the PD-1/PD-L1 pathway, as well as the CTLA-4 pathway

• Immune System Modulators

Yet another type of immunotherapy uses proteins that normally help regulate, or modulate, immune system activity to enhance the body’s immune response against cancer

• Certain growth factors and cytokines, such as interferons and interleukins, are used to modulate immune system response
• Cancer Vaccines
• These are therapeutic vaccines usually made from a patient’s own tumor cells or from substances produced by tumor cells. They are designed to treat cancers that have already developed by strengthening the body’s natural defenses against the cancer.
• Oncolytic Virus
• This is a type of virus that infects and lyses (breaks down) cancer cells but not normal cells

The global immuno-oncology market was valued at US$ 11,060.6 Mn in 2019 and is forecast to reach a value of US$ 37,783.6 Mn by 2027 at a CAGR of 16.5% between 2020 and 2027.

𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/1271

Recent Developments

Major players operating in the global immuno-oncology market are focused on adopting collaboration and partnership strategies to enhance their market share. For instance, in November 2019, Avantor, Inc. collaborated with National Institute for Bioprocessing Research and Training, Ireland, to address downstream issues with buffer preparation when producing monoclonal antibodies.

Global Immuno-Oncology Market: Drivers

Approval and launch of new products is expected to propel growth of the global immuno-oncology market over the forecast period. For instance, Bio-Rad Laboratories, Inc. launched its Bio-Plex Pro Human Immunotherapy Panel 20-plex in July 2019. It is a multiplex immunoassay that offers a targeted approach in immunotherapy R&D.

Moreover, the global immuno-oncology market growth is driven by high incidence of cancer. For instance, according to the Centers of Disease Control and Prevention’s U.S. Cancer Statistics September 2019, around 94,000 women were diagnosed with gynecologic cancer each year, in the U.S., between 2012 and 2016.

Global Immuno-Oncology Market: Opportunities

Expansion of production capabilities is expected to offer lucrative growth opportunities for players in the global immuno-oncology market. For instance, in 2018, Enzo Biochem, Inc. acquired a commercial facility in US to boost the company’s  diagnostic and therapeutic businesses.

Moreover, increasing investment in immuno-oncology is also expected to offer lucrative growth opportunities for players in the global immuno-oncology market. For instance, Agenus Inc. raised US$ 35 million in July 2020.

𝐓𝐨 𝐆𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐇𝐞𝐫𝐞 @ https://www.coherentmarketinsights.com/insight/request-pdf/1271

Market Trends:

Europe is expected to witness significant growth in the global immuno-oncology market, owing to R&D in immunotherapy. For instance, a study from University Hospital Heidelberg, Germany reported that sufficient yield of lymphocytes for CAR-T cell production is viable for patients with low peripheral blood counts. The study was published in May 2020.

Major players operating in the global immuno-oncology market are focused on approval and launch of new products to expand their product portfolio. For instance, the U.S. Food and Drug Administration approved the VENTANA PD-L1 (SP142) Assay from F. Hoffmann-La Roche Ltd. in March 2019. The assay aids in diagnosis of triple-negative breast cancer.

Global Immuno-Oncology Market: Competitive Landscape

Major players operating in the global immuno-oncology market include, Amgen, Inc., Agilent Technologies Inc., Agenus Inc., AstraZeneca Plc, Avantor, Inc., Bristol-Myers Squibb Company, Bio-Rad Laboratories, Inc., Dendreon Corporation (A Sanpower Group Company), Enzo Biochem, Inc., Ferring Pharmaceuticals, F. Hoffmann-La Roche Ltd., Lonza Group, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Sanofi, and Spring Bank Pharmaceuticals, Inc.

Global Immuno-Oncology Market: Segmentation

• By Treatment Type
  • Immune Checkpoint Inhibitors
    • PD-1
    • PD-L1
    • CTLA-4
  • Immune System Modulators
  • Cancer Vaccines
  • Oncolytic Virus
  • Others
• By Disease Type
  • Melanoma
  • Lung Cancer
  • Blood Cancers
  • Renal Cell Carcinoma
  • Prostate Cancer
  • Bladder Cancer
  • Other Cancers
• By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

𝗣𝘂𝗿𝗰𝗵𝗮𝘀𝗲 𝗧𝗵𝗶𝘀 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 𝗮𝗻𝗱 𝗚𝗲𝘁 𝗙𝗹𝗮𝘁 𝟮𝟬𝟬𝟬 𝗢𝗙𝗙

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/1271

Table of Contents

1. Research Objective and Assumption
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Treatment Type
     • Market Snippet, By Disease Type
     • Market Snippet, By End User
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Key Developments
   • Regulatory Scenario
   • PEST Analysis
   • COVID-19 Impact Analysis
4. Global Immuno-Oncology Market, By Treatment Type, 2019 – 2027 (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017–2027
     • Segment Trends
   • Immune Checkpoint Inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
       • PD-1
       • PD-L1
       • CTLA-4
   • Immune System Modulators
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
   • Cancer Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
   • Oncolytic Virus
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
5. Global Immuno-Oncology Market, By Disease Type, 2019 – 2027 (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017–2027
     • Segment Trends
   • Melanoma
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Lung Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Blood Cancers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Renal Cell Carcinoma
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Prostate Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Bladder Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
6. Global Immuno-Oncology Market, By End User, 2019 – 2027 (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017–2027
     • Segment Trends
   • Hospitals
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Clinics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Ambulatory Surgical Centers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)

View Press Release: https://www.coherentmarketinsights.com/press-release/global-immuno-oncology-drugs-market-to-surpass-us-150-billion-threshold-by-2025-globally-662

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837